UPCOMING CLINICAL TRIALS

In our continuing commitment to clinical research and achieving the best outcomes for our patients, Strathfield Retina Clinic will be partaking in four new clinical trials:

CONDOR STUDY

A Phase III, randomized, single-masked, multicenter study assessing the efficacy and safety of brolucizumab 6 mg compared to panretinal photocoagulation laser in patients with Proliferative Diabetic Retinopathy

RHONE-X STUDY

A multicenter, open-label extension study to evaluate the long-term safety and tolerability of faricimab in patients with diabetic macular edema

RIPPLE-1 STUDY

A Phase II evaluation of safety and efficacy of IBE-814 Intravitreal (IVT) Implant in patients with Diabetic Macular Oedema and Macular Oedema due to Retinal Vein Occlusion

PQ-110-001 STUDY

A randomised, double-masked vehicle-controlled, multiple dose, dose escalation study to evaluate the safety and tolerability of EXN407 in subjects with centre involved diabetic macular oedema secondary to diabetes mellitus

---

If you are eligible for any of the above clinical trials, your Ophthalmologist will be able to discuss participation with you at your consultation